RXi Rapid Exchange FFR System Allows Quick, Easy Assessment of FFR Values
The Acist|RXi Rapid Exchange FFR system is the world's first rapid exchange FFR system. This device features new technology designed to provide physicians with a fast and easy way to perform fractional flow reserve (FFR) procedures.
The system utilizes the ultra-thin Acist Navvus Rapid Exchange MicroCatheter and RXi console. The Navvus MicroCatheter can be used over a standard 0.014-inch guidewire, providing the physician maximum control while maintaining wire position throughout the coronary procedure. The RXi system also facilitates rapid FFR assessments before, during and post-intervention, to quickly assess blockages that could require percutaneous coronary intervention (PCI). This technology is the first of its kind, providing the reassurance of accurate and reliable FFR measurements and the advantages of rapid exchange platform.
In addition to being a Rapid Exchange catheter, the Acist Rapid FFR system utilizes fiber-optic technology, resulting in greater signal stability and less potential for signal drift. The ultra-thin Navvus MicroCatheter features simple plug and play by not requiring calibration therefore saving time and increasing ease of use versus older FFR wire-base systems.
The system received 510(k) Food and Drug Administration (FDA) clearance in January 2014.
For more information: www.acist.com